Aspen increases revenue 16% to R41.2 bn

2017年9 月14日
下午 4:30

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a leading global pharmaceutical company, has announced pleasing results for the year ended 30 June 2017.

Download (PDF 86.7KB)

我们的使命

更多详情

致力于提高患者的生命健康和质量

我们的愿景

更多详情

作为一个负责任的企业公民，在全球提高优质和患者可及的药物，传递我们的价值。

我们的价值观

更多详情

我们的价值观是爱施健存立和发展的基石。集团上下以此为指引，为实现集团目标而共同奋斗。

Aspen increases revenue 16% to R41.2 bn

我们的使命

我们的愿景

我们的价值观

关于我们

社会责任

职业发展

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Aspen increases revenue 16% to R41.2 bn

我们的使命

我们的愿景

我们的价值观

关于我们

社会责任

职业发展

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023. The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.